Background. Melasma is a common pigmentary disorder that poses therapeutic challenges. Mixed-type melasma usually does not respond to conventional monotherapy.
Objective. To evaluate the effectiveness and safety of 1064-nm Q-switched neodymium-doped yttrium–aluminium–garnet laser (1064 QNYL) and 30% glycolic acid (GA) peel in the treatment of melasma.
Methods. This was a split-face study, in which 16 patients were treated with 1064 QNYL (6-mm spot size, 2.0–2.3 J/cm2 fluence) for six sessions at 1-week intervals to the entire face, and with GA for three sessions at 2-week intervals to the experimental side of the face. ...
A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium–aluminium–garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma is a post from: Skincare
A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium–aluminium–garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma via BuzzBlazer.com
No comments:
Post a Comment